Caribou Biosciences, Inc.Caribou Biosciences, Inc.Caribou Biosciences, Inc.

Caribou Biosciences, Inc.

No trades
See on Supercharts
Market capitalization
‪379.32 M‬USD
−1.45USD
‪−102.07 M‬USD
‪34.48 M‬USD
‪79.62 M‬
Beta (1Y)
1.94

About Caribou Biosciences, Inc.

CEO
Rachel E. Haurwitz
Headquarters
Berkeley
Employees (FY)
158
Founded
2011
ISIN
US1420381089
FIGI
BBG008G28LJ5
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CRBU is 4.03 USD — it has decreased by 1.11% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Caribou Biosciences, Inc. stocks are traded under the ticker CRBU.
Caribou Biosciences, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Caribou Biosciences, Inc. has a max estimate of 26.00 USD and a min estimate of 10.00 USD.
CRBU earnings for the last quarter are −0.12 USD whereas the estimation was −0.42 USD which accounts for 71.17% surprise. Estimated earnings for the next quarter are −0.37 USD. See more details about Caribou Biosciences, Inc. earnings.
Caribou Biosciences, Inc. revenue for the last quarter amounts to ‪23.66 M‬ USD despite the estimated figure of ‪3.29 M‬ USD. In the next quarter revenue is expected to reach ‪3.95 M‬ USD.
Yes, you can track Caribou Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, CRBU shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Caribou Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
CRBU reached its all-time high on Sep 7, 2021 with the price of 32.65 USD, and its all-time low was 3.44 USD and was reached on Nov 1, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 158.00 employees. See our rating of the largest employees — is Caribou Biosciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Caribou Biosciences, Inc. EBITDA is ‪−109.75 M‬ USD, and current EBITDA margin is −326.40%. See more stats in Caribou Biosciences, Inc. financial statements.